Tu1859 CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH DURABLE RESPONSE TO USTEKINUMAB INDUCTION THERAPY: RESULTS FROM THE UNIFI PHASE 3 STUDIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS
Gastroenterology（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要